We represented AmSurg Corp. (NASDAQ: AMSG) in its merger with Envision Healthcare Holdings, Inc. The combination of Envision Healthcare and AMSURG brought together two leading, complementary healthcare companies to form one of the nation’s largest provider organizations. The combined organization had a pro forma market capitalization of approximately $10 billion and enterprise value of approximately $15 billion based on the closing stock prices of Envision and AMSURG on June 14, 2016.
Envision Healthcare Corporation is co-headquartered in Nashville, Tennessee, and Greenwood Village, Colorado. The company’s common stock began trading on the New York Stock Exchange, December 2, 2016, under the ticker symbol EVHC and became part of the S&P 500 stock index.
The new Envision is the leading provider of physician-led services, ambulatory surgery center management, post-acute care and medical transportation. The company manages a highly differentiated suite of clinical solutions to support health systems, communities and payors, is composed of a significantly diversified business mix of specialties, customers and geographies, and provides a broader continuum of patient care.
Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Additional details about the definitive merger agreement can be found in the official news release posted on Envision’s website.
This transaction was one of six separate deals involving Bass, Berry & Sims that was recognized as a Finalist for the 16th Annual M&A Advisor Awards in the categories of
- M&A Deal of the Year (over $5B)
- Corporate/Strategic Deal of the Year (over $1B)
- Healthcare and Life Sciences Deal of the Year (over $100MM)